Join our host, Solange Peters, for an insightful roundtable on immunotherapies in NSCLC. This interdisciplinary roundtable brings together renowned experts Patrick Forde and Jordi Remon to explore the debate around neoadjuvant immunotherapies, including the question of whether IO alone is sufficient and the importance of embracing additional adjuvant IO. The discussion will also focus on maximizing outcomes with the latest IO combinations, including the role of IO-IO in PD-L1 negative NSCLC, and provide practical guidance on managing immune-related adverse events (irAEs). Don’t miss this opportunity to deepen your understanding, engage with experts through interactive case discussions, and discover the future of IO combination strategies in NSCLC treatment.